Rémi Legay
University of Caen Lower Normandy
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rémi Legay.
Green Chemistry | 2010
Jérôme Baudoux; Pierre Lefebvre; Rémi Legay; Marie-Claire Lasne; Jacques Rouden
Aiming at the development of green and efficient C–C bond formations (aldol and Mannich reactions), the decarboxylative nucleophilic addition of malonic acid half ester to imines or aldehydes under mild metal-free conditions was studied. A careful control of the temperature and the appropriate choice of the organic base allowed us to obtain β-amino esters or β-hydroxy esters including α-substituted and α,α-disubstituted ones in moderate to excellent yields. 1H NMR monitoring of the reaction unveiled two distinct mechanisms depending on the hemimalonate used. With the unsubstituted substrate, a carboxylic acid intermediate was isolated upon acid quench resulting from the nucleophilic addition of the putative enol carboxylate anion of the hemimalonate to imines/aldehydes before CO2 loss. With substituted hemimalonates, the reaction likely involved an enolate which then added to imines/aldehydes or was competitively protonated. According to the base used, the reaction can be carried out either under solvent free-conditions or in an ionic liquid under mild conditions.
Dalton Transactions | 2014
Mathieu J.-L. Tschan; Jia Guo; Sumesh K. Raman; Emilie Brulé; Thierry Roisnel; Marie-Noëlle Rager; Rémi Legay; Guillaume Durieux; Baptiste Rigaud; Christophe M. Thomas
The coordination chemistry of a series of pro-ligands ([L¹]-[L⁶]) with cobalt and zinc derivatives has been studied. All complexes have been characterized by multinuclear NMR, elemental analysis, and by single-crystal X-ray diffraction studies. Polymerization of rac-lactide takes place at 130 °C in the presence of cobalt and zinc complexes to yield polymers under solvent free conditions with controlled molecular masses and narrow polydispersities.
European Journal of Medicinal Chemistry | 2010
Vittoria Perri; Christophe Rochais; Jana Sopkova-de Oliveira Santos; Rémi Legay; Thierry Cresteil; Patrick Dallemagne; Sylvain Rault
Attempts in view to dearomatize some previously reported tripentones with potent antineoplastic activities led in thiophene series to an unexpected hydrogenative desulphurization reaction. The resulting (Z)-phenethylidenepyrrolizinones were tested in vitro over human epidermoid carcinoma KB cell line. The results of this biological evaluation indicated that the tricyclic core of our model can be cleaved with a partial respect of the activity.
Journal of Chemical Information and Modeling | 2012
Jana Sopkova-de Oliveira Santos; Anne Sophie Voisin-Chiret; Grégory Burzicki; Laure Sebaoun; Muriel Sebban; Jean-François Lohier; Rémi Legay; Hassan Oulyadi; Ronan Bureau; Sylvain Rault
Protein-protein interactions are central to many biological processes, from intracellular communication to cytoskeleton assembly, and therefore represent an important class of targets for new therapeutics. The most common secondary structure in natural proteins is an α-helix. Small molecules seem to be attractive candidates for stabilizing or disrupting protein-protein interactions based on α-helices. In our study, we assessed the ability of oligopyridyl scaffolds to mimic the α-helical twist. The theoretical as well as experimental studies (X-ray diffraction and NMR) on conformations of bipyridines in the function of substituent and pyridine nitrogen positions were carried out. Furthermore, the experimental techniques showed that the conformations observed in bipyridines are maintained within a longer oligopyridyl scaffold (quaterpyridines). The alignment of the synthesized quaterpyridine with two methyl substituents showed that it is an α-helix foldamer; their methyl groups overlap very well with side chain positions, i and i + 3, of an ideal α-helix.
Chemistry: A European Journal | 2017
Aurélien Chardon; Tharwat Mohy El Dine; Rémi Legay; Michaël De Paolis; Jacques Rouden; Jérôme Blanchet
A reduction of various aryl, alkyl, and α,β-unsaturated amides with phenylsilane, catalysed by a borinic acid, is reported. The unprecedented reaction was carried out under very mild conditions and led to useful amines. Furthermore, the reaction tolerates a variety of functional groups. Initial investigations implicated that an intermediate diarylhydroborane is involved in the reaction mechanism.
Chemical Biology & Drug Design | 2013
Dominique Brossard; Ying Zhang; Shozeb Haider; Miriam Sgobba; Mohamed Khalid; Rémi Legay; Martine Duterque-Coquillaud; Philippe Galéra; Sylvain Rault; Patrick Dallemagne; Safa Moslemi; Laïla El Kihel
Nine new 17‐(piperazin‐1‐yl)pyridin‐5‐yl)steroids as abiraterone analogues were synthesized. Compounds 5d and 5g showed selective activities against 17α‐hydroxylase/C17,20‐lyase (CYP17A1) and aromatase (CYP19), respectively. IC50 values of 5d were 5.09 and >50 μm, whereas these values for 5g were >50 μm and 7.40 μm, respectively, for CYP17A1 and CYP19. Molecular modelling highlighted that the inhibitor designed to bind cytochrome P450 haem iron is a necessary condition but not the only rationale to explain inhibitory activity. These abiraterone analogues were then evaluated on hormone‐independent prostate cancer cell lines DU‐145 and PC‐3 and on hormone‐dependent breast and prostate cancer cell lines MCF‐7 and LNCaP, respectively. Compounds 5e, 5g and 5i have showed potent activities only on hormone‐independent prostate cancer cell lines DU‐145 and PC‐3 with 60–85% inhibition of both cell viability and growth at 10 nm with pro‐apoptotic mechanism as illustrated in PC‐3 cells by DNA ladder assay and Western blotting of Bax, Casp‐3 and its substrate, the poly (ADP–ribose) polymerase. We conclude that hybrid heterocycle steroids could be good lead compounds in the drug design especially against hormone‐independent prostate cancer.
Bioorganic & Medicinal Chemistry | 2012
Elizabeth Chosson; Francesca Santoro; Christophe Rochais; Jana Sopkova-de Oliveira Santos; Rémi Legay; Sylviane Thoret; Thierry Cresteil; Maria Stefania Sinicropi; Thierry Besson; Patrick Dallemagne
The synthesis of 7-oxo and 7-hydroxy trifluoroallocolchicinoids was achieved through the intramolecular cyclization of o-phenyl-β-phenylalanines. The resulting compounds were evaluated for their cytotoxic activity against KB cells and their inhibitory effect towards the polymerization of tubulin. The results yielded some potent cytotoxic compounds with correlated partial antitubulin effect.
MedChemComm | 2013
David Genest; Christophe Rochais; Cédric Lecoutey; Jana Sopkova-de Oliveira Santos; Céline Ballandonne; Sabrina Butt-Gueulle; Rémi Legay; Marc Since; Patrick Dallemagne
The synthesis of eighteen novel (thia)indanopyrazole derivatives was achieved starting from amino(thia)indanones. Some of them displayed a dual binding site acetylcholinesterase inhibition which makes them potentially interesting for Alzheimers disease treatment.
European Journal of Medicinal Chemistry | 2016
Jean-Pierre Jourdan; Marc Since; Laïla El Kihel; Cédric Lecoutey; Sophie Corvaisier; Rémi Legay; Jana Sopkova-de Oliveira Santos; Thierry Cresteil; Aurélie Malzert-Fréon; Christophe Rochais; Patrick Dallemagne
This work describes the synthesis and the biological evaluation of novel benzylidenephenylpyrrolizinones as potential antioxidant, metal chelating or amyloid β (βA) aggregation inhibitors. Some derivatives exhibited interesting results in regard to several of the performed evaluations and appear as valuable Multi-Target Directed Ligands with potential therapeutic interest in Alzheimers disease. Among them, compound 29 particularly appears as a valuable radical and NO scavenger, a Cu(II) and Fe(II) chelating agent and exhibits moderate βA aggregation inhibition properties. These activities, associated to a good predictive bioavailability and a lack of cytotoxicity, design it as a promising hit for further in vivo investigation.
European Journal of Medicinal Chemistry | 2018
Siham Hedir; Marcella De Giorgi; Jade Fogha; Martina De Pascale; Louis-Bastien Weiswald; Emilie Brotin; Bogdan Marekha; Christophe Denoyelle; Camille Denis; Peggy Suzanne; Fabien Gautier; Philippe Juin; Laetitia Ligat; Frédéric Lopez; Ludovic Carlier; Rémi Legay; Ronan Bureau; Sylvain Rault; Laurent Poulain; Jana Sopkova-de Oliveira Santos; Anne Sophie Voisin-Chiret
Protein-protein interactions are attractive targets because they control numerous cellular processes. In oncology, apoptosis regulating Bcl-2 family proteins are of particular interest. Apoptotic cell death is controlled via PPIs between the anti-apoptotic proteins hydrophobic groove and the pro-apoptotic proteins BH3 domain. In ovarian carcinoma, it has been previously demonstrated that Bcl-xL and Mcl-1 cooperate to protect tumor cells against apoptosis. Moreover, Mcl-1 is a key regulator of cancer cell survival and is a known resistance factor to Bcl-2/Bcl-xL pharmacological inhibitors making it an attractive therapeutic target. Here, using a structure-guided design from the oligopyridine lead Pyridoclax based on Noxa/Mcl-1 interaction we identified a new derivative, active at lower concentration as compared to Pyridoclax. This new derivative selectively binds to the Mcl-1 hydrophobic groove and releases Bak and Bim from Mcl-1 to induce cell death and sensitize cancer cells to Bcl-2/Bcl-xL targeting strategies.